CLOROTEKAL

Peak

chloroprocaine hydrochloride

NDAINTRATHECALSOLUTION
Approved
Sep 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1

Mechanism of Action

CLINICAL PHARMACOLOGY Chloroprocaine, like other local anesthetics, blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse and by reducing the rate of rise of the…

Clinical Trials (1)

NCT02067806N/ACompleted

Observational Study on 2-chloroprocaine Hydrochloride 1%

Started Nov 2013
394 enrolled
Neurological Complication, in Particular TNS or CES

Loss of Exclusivity

LOE Date
Dec 11, 2033
94 months away
Patent Expiry
Dec 11, 2033

Patent Records (2)

Patent #ExpiryTypeUse Code
8969412
Sep 5, 2026
Product
U-2609
9504666
Dec 11, 2033
Product